🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of depemokimab (GSK3511294...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-20
Trial ID
NCT07701967
Treatments Being Tested
This study is aimed at assessing depemokimab as an add-on medicine for the ...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-06-25
Trial ID
NCT07671001
Treatments Being Tested
This study will evaluate the efficacy and safety of depemokimab (GSK3511294...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-04-18
Trial ID
NCT05281523
Treatments Being Tested
This is a multi-center, randomized, placebo-controlled, double-blind, paral...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-03-17
Trial ID
NCT04719832
Treatments Being Tested
Depemokimab is being developed as a treatment for individuals with moderate...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-06-23
Trial ID
NCT06961214
Treatments Being Tested
This study will assess whether switching participants who have benefitted f...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-26
Trial ID
NCT04718389
The aim of this study is to evaluate the efficacy of depemokimab administer...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-03-13
Trial ID
NCT07456033
Treatments Being Tested
This single dose pharmacokinetic (PK) study aims to investigate the PK, saf...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-12-10
Trial ID
NCT05140200
Treatments Being Tested
This study will assess the efficacy and safety of GSK3511294 (Depemokimab) ...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-02-04
Trial ID
NCT04718103
Treatments Being Tested
The purpose of this open-label 12-month extension study is to continue to c...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-03-01
Trial ID
NCT05243680
Treatments Being Tested